| Date | Title | | | 05/23/13 | Greenway Earns Two U.S. Patents for Care-Coordination Technology| Health Information Solution Provider Now Holds Four Patents for
Usability, Data Liquidity, Connectivity and Access
CARROLLTON, Ga.--(BUSINESS WIRE)--May. 23, 2013--
Greenway Medical Technologies, Inc., which delivers innovative
information solutions for healthcare providers, has been granted two new
U.S. patents related to electronic quality-of-care data liquidity. Both
patents cover the receipt and transmission of data from multiple
electroni... |
|  | | 05/22/13 | Greenway Extends Family of EHR Mobile Apps to Windows 8| Mobile Access Solution for PrimeSUITE EHR Available on Providers’
Choice of iOS, Android and Windows Personal Devices
CARROLLTON, Ga.--(BUSINESS WIRE)--May. 22, 2013--
Greenway Medical Technologies, Inc., which delivers innovative
information solutions for healthcare providers, announced today that
PrimeMOBILE™, Greenway’s mobile access solution for
PrimeSUITE® electronic health record customers, is now
Microsoft-certified and availabl... |
| | | 05/06/13 | Greenway Reports Fiscal 2013 Third-Quarter Results| CARROLLTON, Ga.--(BUSINESS WIRE)--May. 6, 2013-- Greenway Medical Technologies, Inc. (NYSE: GWAY), which delivers innovative software and business service solutions for healthcare care providers through its PrimeSUITE® platform, today announced financial results for the three months and nine months ended March 31, 2013.
“Our efforts to shift the adoption of our PrimeSUITE platform from license sales to cloud-based services has accelerated the shift in our revenue streams to recurring sources d... |
| | | 04/29/13 | Greenway Revises Fiscal 2013 Outlook| Expects Revenue of $132-$134 million, Adjusted EBITDA of $5.8-$6.8 million
CARROLLTON, Ga.--(BUSINESS WIRE)--Apr. 29, 2013-- Based on its preliminary results for the third quarter of fiscal 2013 as well as its estimates for the fiscal fourth quarter, Greenway Medical Technologies, Inc. (NYSE: GWAY), is revising its previously issued outlook for its 2013 fiscal year that will end June 30, 2013, to include expected revenue of $132 million to $134 million, and adjusted EBITDA of $5.8 million to $... |
| |
|
